DIAO Sha 1,2,3,4 , LI Siyu 1,2,3,4,5 , SHI Yuqing 1,2,3,4,6 , LIU Zheng 1,2,3,4,5 , KANG Deying 7 , LIU Guanjian 7 , ZHAO Rongsheng 8 , ZENG Linan 1,2,3,4 , YI Qiusha 1,2,3,4 , LI Hailong 1,2,3,4 , HUANG Chao 9 , WANG Qiang 9 , ZHANG Lingli 1,2,3,4,7
  • 1. Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 2. Evidence-based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 3. NMPA Key Laboratory for Technical Research on Drug Products in vitro and in vivo Correlation, Chengdu 610041, P. R. China;
  • 4. Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Chengdu 610041, P. R. China;
  • 5. West China School of Medicine, Sichuan University, Chengdu 610041, P. R. China;
  • 6. West China School of Pharmacy, Sichuan University, Chengdu 610041, P. R. China;
  • 7. Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 8. Department of Pharmacy, Peking University Third Hospital, Beijing 100191, P. R. China;
  • 9. Medical Management Service Guidance Center, National Health Commission of the People’s Republic of China, Beijing 100044, P. R. China;
WANG Qiang, Email: jason2019@sina.cn; ZHANG Lingli, Email: zhanglingli@scu.edu.cn
Export PDF Favorites Scan Get Citation

The instrument for evaluating clinical applicability of guidelines (version 2.0) is designed to evaluate the clinical applicability of guidelines quantitatively. It is helpful to select guidelines with high clinical applicability and provide suggestions for revision. The evaluators are consistent with the target users of guidelines. The instrument consists of basic information, evaluation items and scoring scheme. The evaluation items are related to accessibility, readability, acceptability, feasibility and overall evaluation. Therefore, this article provides a detailed interpretation of the instrument and references for future users.

Citation: DIAO Sha, LI Siyu, SHI Yuqing, LIU Zheng, KANG Deying, LIU Guanjian, ZHAO Rongsheng, ZENG Linan, YI Qiusha, LI Hailong, HUANG Chao, WANG Qiang, ZHANG Lingli. Interpretation of the instrument for evaluating clinical applicability of guidelines (version 2.0). Chinese Journal of Evidence-Based Medicine, 2023, 23(11): 1318-1322. doi: 10.7507/1672-2531.202304080 Copy

  • Previous Article

    Research on the framework and functional items construction of a scientific research assistant tool for conducting systematic review for patient-reported outcome measures based on the COSMIN method
  • Next Article

    Construct a comprehensive evaluation index system for the rational use of foods for special medical purposes (FSMP) in medical institutions